Patient recruitment

CB Insights Ranks Verana Health as a Leader in EHR-based Patient Recruitment Market

Retrieved on: 
Wednesday, March 6, 2024
SAN, Ophthalmology, Urology, Physician, Quality of life, CB Insights, EHR, CB, Neurology, ChromeOS, Health, Patient, Data analysis, Patient recruitment, Diagnosis, American Urological Association, American Academy, Pharmaceutical industry

SAN FRANCISCO, March 06, 2024 (GLOBE NEWSWIRE) -- Today, Verana Health®, a digital health company dedicated to revolutionizing patient care and clinical research through real-world data, announced that CB Insights ranked Verana Health as a Leader in the EHR-based patient recruitment market.

Key Points: 
  • SAN FRANCISCO, March 06, 2024 (GLOBE NEWSWIRE) -- Today, Verana Health®, a digital health company dedicated to revolutionizing patient care and clinical research through real-world data, announced that CB Insights ranked Verana Health as a Leader in the EHR-based patient recruitment market.
  • This market is dedicated to leveraging electronic health record (EHR) data to amplify the efficiency and effectiveness of identifying eligible patients for clinical trials.
  • “This ranking from CB Insights underscores our team’s commitment to delivering innovative solutions that can help improve patient outcomes,” said Verana Health CEO Sujay Jadhav.
  • Last year, Verana Health also launched multiple Qdata ® modules across the three therapeutic areas of ophthalmology, neurology, and urology.

A Collaborative Approach to Advancing Access and Equity in Rare Disease Clinical Trials, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Tuesday, February 13, 2024
Rare disease, Collection, Bachelor of Science, Pompe, RN, Clinical trial, Amicus Therapeutics, Patient, Patient recruitment, Sponsor, MBBS, Trial of the century, Pharmaceutical industry

TORONTO, Feb. 13, 2024 /PRNewswire-PRWeb/ -- Ensuring that all patients have equal access to participate in clinical trials across all geographies has become essential throughout the industry. Patient recruitment and retention remain one of the most challenging hurdles in clinical development, particularly for rare diseases. Implementing a patient-focused clinical trial design and fostering a collaborative approach between the Sponsor, CRO, sites, and advocacy groups can help lead to successful clinical trials.

Key Points: 
  • The featured speakers will discuss how to engage and support patients in rare disease clinical trials.
  • Implementing a patient-focused clinical trial design and fostering a collaborative approach between the Sponsor, CRO, sites, and advocacy groups can help lead to successful clinical trials.
  • In this webinar, Medpace , a global full-service CRO, will discuss the importance of equity in patient-friendly rare disease trials.
  • Register now for the Rare Disease Day 2024 webinar to join the discussion with clinical trial experts on a collaborative approach to patient-friendly trials in rare disease.

Trialbee to Host Virtual Panel on 5 'Must Haves' in New Era of Patient Recruitment with Coloplast and Wright State Physicians on September 19

Retrieved on: 
Monday, September 11, 2023
Honey, New Era, Clinical trial, It Must Have Been Love, Patient, Patient recruitment, CEST, Empathy, Pharmaceutical industry, Nursing, Coloplast

CHAPEL HILL, N.C. and MALMO, Sweden, Sept. 11, 2023 /PRNewswire-PRWeb/ -- Trialbee, the leader in data and technology-based patient recruitment for global clinical trials, will present "The Five 'Must Haves' in the New Era of Patient Recruitment," an important and engaging virtual panel that focuses on the advent of new technology in patient recruitment and the evolving role of the people who support it.

Key Points: 
  • The conversation, moderated by industry advisor Craig Lipset, will include insight from Trialbee CEO Matt Walz, Coloplast senior director of clinical trial patient recruitment Martin Karup, and Wright State Physicians clinical trial liaison Alycia Ketter.
  • The conversation will take place on Tuesday, Sept. 19, at 4 p.m. CEST (10 a.m. U.S.
  • ET) and include insight from Trialbee CEO Matt Walz , Coloplast senior director of clinical trial patient recruitment Martin Karup , and Wright State Physicians clinical trial liaison Alycia Ketter .
  • "Although it enables efficiency and scale, technology cannot stand alone in addressing the challenges posed by global patient recruitment and enrollment for clinical trials," Walz said.

Patient Recruitment Services and Patient Retention Services Market by Therapeutic Area, Patient Recruitment Step, Trial Phase and Key Geographies: Industry Analysis and Global Forecasts, 2022-2035

Retrieved on: 
Friday, December 2, 2022
Real-World Evidence, Geography, Patient recruitment, Degenerative disease, Safety, Neurological disorder, Clinical trial, App Store (iOS/iPadOS), Patient, Communications manager, Fear, Q5, RWE, Central nervous system, CNS, Pinterest, Infection, Partnership, Element, EHR, Kate Shaw, Central nervous system disease, Ethics, EC, Pain, Marketing, Transport, IRB, COVID-19, Laika (EHR testing framework), Pharmacy, III, Communication, Growth, Therapy, Artificial intelligence, Social media, Electronic health record, Chief business development officer, Health information management, Pharmaceutical industry, Employment agency, Risk management, Medicine, Medical imaging, Medical device, Management, USD

In fact, a number of modern technology-enabled offerings are now available to support various aspects of clinical research and patient recruitment.

Key Points: 
  • In fact, a number of modern technology-enabled offerings are now available to support various aspects of clinical research and patient recruitment.
  • What is the current market landscape of the patient recruitment and retention services market?
  • Presently, more than 155 companies have the required capabilities to offer patient recruitment and retention services across different geographical locations.
  • A detailed assessment on the impact of the COVID-19 pandemic on the patient recruitment and retention services market.

Vial: Faster, Better, Cheaper CRO Powered by Technology, Announces Series B led by General Catalyst

Retrieved on: 
Wednesday, November 30, 2022
Data collection, ESourcing Capability Model, SAN, Cardiology, Communication, Patient recruitment, General Catalyst, Silicon, Cros, Cdx, Multimedia, PDF, BoxGroup, EMR, European Technology Platform on Smart Systems Integration, Dermatology, Ophthalmology, Gastroenterology, Cras, Neurology, Entrepreneurship, Clinical trial, Fine chemical, Vial, Microsoft Excel

Together the teams collaborated on building a technology platform that drives efficiencies in every step of a clinical trial.

Key Points: 
  • Together the teams collaborated on building a technology platform that drives efficiencies in every step of a clinical trial.
  • Vial's Technology Platform is made up of three key platforms: Site Startup platform, eSource platform and Patient Recruiting platform.
  • Vial is the CRO sponsors can trust to be a true partner and deliver for their clinical trials.
  • Vial operates across multiple therapeutic areas ( Dermatology CRO , Ophthalmology CRO , Oncology CRO , Gastroenterology CRO , Neurology CRO , and Cardiology CRO ).

Waterdrop Co-founder Yao Hu Shares Progress in Pharmaceutical Innovation

Retrieved on: 
Friday, November 18, 2022
Digital, Shanghai United Media Group, R, Insurance, Marketing, NYSE, WDH, Patient, Clinical trial, Patient recruitment, Pharmaceutical industry, Health insurance, Waterdrop

BEIJING, Nov. 18, 2022 /PRNewswire/ -- On November 16, Mr. Yao Hu, co-founder of Waterdrop and General Manager of the Pharmaceutical Innovation Business Unit, attended the Jiemian(Jiemian.com) Big Health Forum 2022 sponsored by Shanghai United Media Group, at which he shared the exploration and headway Waterdrop has made in pharmaceutical innovation over the last two years.

Key Points: 
  • BEIJING, Nov. 18, 2022 /PRNewswire/ -- On November 16, Mr. Yao Hu, co-founder of Waterdrop and General Manager of the Pharmaceutical Innovation Business Unit, attended the Jiemian(Jiemian.com) Big Health Forum 2022 sponsored by Shanghai United Media Group, at which he shared the exploration and headway Waterdrop has made in pharmaceutical innovation over the last two years.
  • Hu said, Waterdrop has made "bringing insurance and healthcare service to billions through technology"its mission since it was established in 2016.
  • While serving patients, Waterdrop has developed a chain of healthcare-related services and launched the pharmaceutical innovation service to offer platforms for the pharmaceutical industry.
  • Hu said, "Focusing on millions of patients with severe illness, Waterdrop's pharmaceutical innovation service aims to speed up the R&D of innovative drugs and promote digital marketing for pharmaceutical enterprises.

Considerations for Patient Diversity in Cardiovascular Clinical Trials, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Thursday, May 12, 2022
Patient, Industry, University of Pennsylvania Health System, FACC, CCRP, CRO, Patient recruitment, Food, Pharmaceutical industry, Medical device, Medpace, Medicine, MD

TORONTO, May 12, 2022 /PRNewswire-PRWeb/ -- Patient diversity in clinical research populations has become a strategic focus of stakeholders throughout the industry and by regulatory authorities throughout the world. There are many common challenges in the recruitment and retention of diverse populations for participation in clinical trials. But, with the right strategy, an ongoing commitment to ensuring representation and a collaborative effort between the CRO, the sponsor and investigative sites, representative diversity in trial populations can be achieved. The key to achieving representative patient diversity in clinical trials is to understand the importance of selecting the correct mix of diversity strategies to create a nuanced, protocol-specific diversity initiative.

Key Points: 
  • In this free webinar, learn about the importance of achieving diversity, equity and inclusion in clinical trials.
  • TORONTO, May 12, 2022 /PRNewswire-PRWeb/ -- Patient diversity in clinical research populations has become a strategic focus of stakeholders throughout the industry and by regulatory authorities throughout the world.
  • The key to achieving representative patient diversity in clinical trials is to understand the importance of selecting the correct mix of diversity strategies to create a nuanced, protocol-specific diversity initiative.
  • For more information, or to register for this event, visit Considerations for Patient Diversity in Cardiovascular Clinical Trials.

Cloudbyz Achieves ISO 9001:2015 Certification for Quality Management

Retrieved on: 
Tuesday, November 9, 2021
Compliance, Safety, CTMS, Software as a service, Industry, Bureau Veritas, Organization, EPRO, ISO, International Organization (journal), Clinical trial, List of life sciences, Patient recruitment, Solution, ISO 9001:2015, Takraf India Pvt. Ltd., Certification, Project portfolio management, Guest appearance, Clinical trial management system, EDC, Clinical research, Medical device, Risk management

ISO 9001:2015 is a globally recognized quality standard developed and published by the International Organization for Standardization (ISO).

Key Points: 
  • ISO 9001:2015 is a globally recognized quality standard developed and published by the International Organization for Standardization (ISO).
  • The certification authenticates organizations' use of the ISO model to build an effective quality management system.
  • The standard is based on several quality management principles, including strong customer focus, the involvement of organizations' upper management and leadership structures, an outlined, process-based approach, and ongoing improvement of the quality management approach.
  • Commenting on Cloudbyz's certification, Cloudbyz CEO Dinesh Kashyap stated "Our ISO 9001:2015 certification is confirmation of our ongoing commitment to the highest quality, compliance, and safety.

Cloudbyz Launches Decentralized Clinical Trial Solutions

Retrieved on: 
Thursday, August 12, 2021
Time, Multimedia, Form 1099, Cros, Guest appearance, CRO, Clinical trial, DCT, Salesforce, EPRO, LinkedIn, Safety, Patient, Twitter, Compliance, Patient recruitment, Clinical research, Organization, View, Efficiency, SDV, CTMS, EDC, Solution, Pharmaceutical industry, Medical imaging

CHICAGO, Aug. 12, 2021 /PRNewswire/ -- Cloudbyz has launched Decentralized Clinical Trial Solutions (DCT).

Key Points: 
  • CHICAGO, Aug. 12, 2021 /PRNewswire/ -- Cloudbyz has launched Decentralized Clinical Trial Solutions (DCT).
  • Cloudbyz Decentralized clinical trial solutions have the capability for resolving the barriers of time and money.
  • Cloudbyz DCT solution built on the Salesforce platform is a unique product with improved digital capabilities throughout clinical trial lifecycles.
  • Cloudbyz is a fast-growing integrated Clinical Research and development solution provider with integrated capabilities covering Clinical Trial Management Solution (CTMS), Patient Recruitment , eTMF , EDC, eConsent , ePRO, eCOA, Decentralized and Virtual trials and Safety & Pharmacovigilance .

Velocity Clinical Research strengthens management team amid European expansion

Retrieved on: 
Thursday, August 12, 2021
Site, PPD, II, Claris, CRO, COVID, Contract, Novartis, Patient recruitment, Growth, III, Sale, Regulation, Industry, Pharmaceutical industry, Management

DURHAM, NC., Aug. 12, 2021 /PRNewswire/ -- The world's largest integrated clinical trial site organisation, Velocity Clinical Research ("Velocity"), today announces it has strengthened its management team as it embarks on European expansion.

Key Points: 
  • DURHAM, NC., Aug. 12, 2021 /PRNewswire/ -- The world's largest integrated clinical trial site organisation, Velocity Clinical Research ("Velocity"), today announces it has strengthened its management team as it embarks on European expansion.
  • Dr G. Paul Evans, Chief Executive and President of Velocity Clinical Research, said, "Velocity is carving out a new category of pharma services.
  • The clinical trials site landscape will look very different in the next 12 months and Velocity is well placed to take advantage of this consolidation in the market.
  • Dominic Clavell joins Velocity to head up its European operations after a decorated career in some of the top clinical research organisations, site management organisations and pharmaceutical companies in the world, such as Parexel, IQVIA, Synexus and Novartis.